TNFSF10 and neoplasm: FTY720, by synergizing with TNF-related apoptosis inducer ligand (TRAIL), has also been shown to reduce tumor burden and induce tumor-specific apoptosis in xenograft breast cancer models without affecting normal cells (Woo et al., 2015).